Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +1.52% advanced 2.84% to $85.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.80% rising 1.97% to 3,719.04 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.17% rising 1.88% to 29,683.74. The stock's rise snapped a six-day losing streak. DaVita Inc. closed $39.68 short of its 52-week high ($124.81), which the company achieved on April 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +0.65% rose 2.69% to $14.13, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH -0.11% rose 2.60% to $212.02, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.64% rose 3.56% to $90.94. Trading volume (469,834) remained 278,810 below its 50-day average volume of 748,644.